PATH-38. ROSETTE-FORMING GLIONEURONAL TUMOR IS DEFINED BY FGFR1 ACTIVATING ALTERATIONS WITH FREQUENT ACCOMPANYING PI3K AND MAPK PATHWAY MUTATIONS

Rosette-forming glioneuronal tumor (RGNT) is an uncommon CNS tumor originally described in the fourth ventricle characterized by a low-grade glial neoplasm admixed with a rosette-forming neurocytic component. We reviewed clinicopathologic features of 42 patients with RGNT. Targeted next-generation sequencing was performed, and genome-wide methylation profiling is underway. The 20 male and 22 female patients had a mean age of 25 years (range 3–47) at time of diagnosis. Tumors were located within or adjacent to the lateral ventricle (n=16), fourth ventricle (15), third ventricle (9), and spinal cord (2). All 31 tumors assessed to date contained FGFR1 activating alterations, either in-frame gene fusion, kinase domain tandem duplication, or hotspot missense mutation in the kinase domain (p.N546 or p.K656). While 7 of these 31 tumors harbored FGFR1 alterations as the solitary pathogenic event, 24 contained additional pathogenic alterations within PI3-kinase or MAP kinase pathway genes: 5 with additional PIK3CA and NF1 mutations, 4 with PIK3CA mutation, 3 with PIK3R1 mutation (one of which also contained focal RAF1 amplification), 5 with PTPN11 mutation (one with additional PIK3R1 mutation), and 2 with NF1 deletion. The other 5 cases demonstrated anaplastic features including hypercellularity and increased mitotic activity. Among these anaplastic cases, 3 harbored inactivating ATRX mutations and two harbored CDKN2A homozygous deletion, in addition to the FGFR1 alterations plus other PI3-kinase and MAP kinase gene mutations seen in those RGNT without anaplasia. Independent of ventricular location, RGNT is defined by FGFR1 activating mutations or rearrangements, which are frequently accompanied by mutations involving PIK3CA, PIK3R1, PTPN11, NF1, and KRAS. Whereas pilocytic astrocytoma and ganglioglioma are characterized by solitary activating MAP kinase pathway alterations (e.g. BRAF fusion or mutation), RGNT are genetically more complex with dual PI3K-Akt-mTOR and Ras-Raf-MAPK pathway activation. Rare anaplastic examples may show additional ATRX and/or CDKN2A inactivation.

[1]  N. S. van den Berg,et al.  First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800 , 2018, Journal of Neuro-Oncology.

[2]  D. Born,et al.  Why do inguinal hernia patients have pain? Histology points to compression neuropathy. , 2017, American journal of surgery.

[3]  H. Vogel,et al.  The Unusual Presentation of a Myxoma Within the Sphenoid Sinus: Case Report and Review of the Literature. , 2017, World neurosurgery.

[4]  M. Barna,et al.  The p53 family members have distinct roles during mammalian embryonic development , 2017, Cell Death and Differentiation.

[5]  I. Weissman,et al.  CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. , 2016, The Journal of clinical investigation.

[6]  Deshka S. Foster,et al.  Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy , 2016, Oncotarget.

[7]  David T. W. Jones,et al.  Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis , 2016, Acta Neuropathologica.

[8]  B. Rutt,et al.  Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease , 2015, Neurobiology of Aging.

[9]  D. Born,et al.  Periostin is a novel therapeutic target that predicts and regulates glioma malignancy. , 2015, Neuro-oncology.

[10]  H. Vogel,et al.  Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient. , 2015, Clinical neuropathology.

[11]  H. Vogel,et al.  Atypical and rare variants of central neurocytomas. , 2015, Neurosurgery clinics of North America.

[12]  H. Vogel,et al.  Endoscopic resection of a giant intradural retroclival ecchordosis physaliphora: surgical technique and literature review. , 2014, World neurosurgery.

[13]  J. Higgins,et al.  Abnormal Hepatocellular Mitochondria in Methylmalonic Acidemia , 2014, Ultrastructural pathology.

[14]  D. Silbergeld,et al.  Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. , 2014, The Journal of clinical investigation.

[15]  K. Yeom,et al.  MRI Surrogates for Molecular Subgroups of Medulloblastoma , 2014, American Journal of Neuroradiology.

[16]  D. Scholtens,et al.  Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. , 2014, The Journal of clinical investigation.

[17]  David Basanta,et al.  Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status. , 2014, Neuro-oncology.

[18]  Christopher W Mount,et al.  Neuronal Activity Promotes Oligodendrogenesis and Adaptive Myelination in the Mammalian Brain , 2014, Science.

[19]  D. Born,et al.  A Case of Malignant Peripheral Nerve Sheath Tumor of the Hypoglossal Nerve after Stereotactic Radiosurgery Treatment , 2014, Journal of Neurological Surgery Reports.

[20]  T. Speed,et al.  A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression , 2014, Genes & development.

[21]  K. Jensen,et al.  Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III. , 2014, Cancer research.

[22]  H. Vogel,et al.  Highly proliferative sellar chordoma with unusually rapid recurrence , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

[23]  S. Luo,et al.  A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with marfan and loeys–dietz syndrome , 2013, American journal of medical genetics. Part A.

[24]  I. Graef,et al.  AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin , 2013, Proceedings of the National Academy of Sciences.

[25]  K. Jensen,et al.  Abstract 3733: Defining and targeting a Glioblastoma cancer stem cell population with EGF Receptor Variant III. , 2013 .

[26]  Jun Z. Li,et al.  Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies. , 2013, Brain : a journal of neurology.

[27]  P. V. D. van der Starre,et al.  Late profound muscle weakness following heart transplantation due to danon disease , 2013, Muscle & nerve.

[28]  K. Aldape,et al.  Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. , 2012, Annals of diagnostic pathology.

[29]  Andreas Buja,et al.  Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism , 2011, Proceedings of the National Academy of Sciences.

[30]  S. Thorgeirsson,et al.  Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway , 2011, The Journal of experimental medicine.

[31]  H. Vogel,et al.  Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liver. , 2011, Journal of hepatology.

[32]  I. Weissman,et al.  Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma , 2011, Proceedings of the National Academy of Sciences.

[33]  J. Stockman,et al.  A Network Model of a Cooperative Genetic Landscape in Brain Tumors , 2011 .

[34]  H. Vogel,et al.  Brain Abscess Caused by Phaeoacremonium parasiticum in an Immunocompromised Patient , 2010, Journal of Clinical Microbiology.

[35]  J. McKenney,et al.  Loss of SMARCB1/INI1 expression in poorly differentiated chordomas , 2010, Acta Neuropathologica.

[36]  Peter G Schultz,et al.  An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. , 2010, Cell stem cell.

[37]  H. Vogel,et al.  Timing of Bone Marrow Cell Delivery Has Minimal Effects on Cell Viability and Cardiac Recovery After Myocardial Infarction , 2010, Circulation Cardiovascular Imaging.

[38]  H. Vogel,et al.  Unlike p53, p27 failed to exhibit an anti-tumor genetic interaction with Ku80 , 2009, Cell cycle.

[39]  Markus Bredel,et al.  Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. , 2009, JAMA.

[40]  R. West,et al.  The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. , 2009, American journal of clinical pathology.

[41]  H. Vogel,et al.  Papillary tumor of the spinal cord. Report of two cases , 2008, The American journal of surgical pathology.

[42]  Steven D Chang,et al.  Suprasellar giant cell ependymoma: a rare neoplasm in a unique location. , 2008, Human pathology.

[43]  U. Francke,et al.  Severe congenital encephalopathy caused by MECP2 null mutations in males: central hypoxia and reduced neuronal dendritic structure , 2008, Clinical genetics.

[44]  M. Beal,et al.  Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery , 2008, Proceedings of the National Academy of Sciences.

[45]  L. Shuer,et al.  Intracerebral hemorrhage caused by cerebral amyloid angiopathy in a 53-year-old man , 2008, Journal of Neurology.

[46]  H. Vogel,et al.  Muscle lymphocytic infiltrates in thymoma-associated myasthenia gravis are phenotypically different from those in polymyositis , 2007, Neuromuscular Disorders.

[47]  H. Vogel,et al.  Deletion of Ku80 causes early aging independent of chronic inflammation and Rag-1-induced DSBs , 2007, Mechanisms of Ageing and Development.

[48]  D. Born,et al.  The Effect of Binge Fetal Alcohol Exposure on the Number of Vasoactive Intestinal Peptide-Producing Neurons in Fetal Sheep Brain , 2007, Developmental Neuroscience.

[49]  Steven D Chang,et al.  A 35‐YEAR‐OLD WOMAN WITH A DURAL‐BASED MASS , 2007, Brain pathology.

[50]  M. Beal,et al.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A. Bradley,et al.  p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  David S. Lapointe,et al.  Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. , 2006, The American journal of pathology.

[53]  L. Recht,et al.  Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  H. Vogel,et al.  Gigaxonin Interacts with Tubulin Folding Cofactor B and Controls Its Degradation through the Ubiquitin-Proteasome Pathway , 2005, Current Biology.

[55]  S. Lowe,et al.  p63 deficiency activates a program of cellular senescence and leads to accelerated aging. , 2005, Genes & development.

[56]  H. Vogel,et al.  NF90 Regulates Cell Cycle Exit and Terminal Myogenic Differentiation by Direct Binding to the 3′-Untranslated Region of MyoD and p21WAF1/CIP1 mRNAs* , 2005, Journal of Biological Chemistry.

[57]  S. Tanner,et al.  Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations , 2005, Neurology.

[58]  J. Pollack,et al.  Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. , 2005, The Journal of molecular diagnostics : JMD.

[59]  Michael B. Mann,et al.  Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome. , 2005, Human molecular genetics.

[60]  John W. Miller,et al.  Progression from frontal-parietal to mesial-temporal epilepsy after fluid percussion injury in the rat. , 2004, Brain : a journal of neurology.

[61]  H. Vogel Burden of Proof in the Postmortem Diagnosis of Mitochondrial Disease: Leigh Disease , 2004, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[62]  J. Belmont,et al.  Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease , 2004, Pediatrics.

[63]  F. Scaglia,et al.  Novel homoplasmic mutation in the mitochondrial tRNATyr gene associated with atypical mitochondrial cytopathy presenting with focal segmental glomerulosclerosis , 2003, American journal of medical genetics. Part A.

[64]  G. Fuller,et al.  Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems. , 2003, Annals of diagnostic pathology.

[65]  J. Lupski,et al.  COP9 Signalosome Subunit 3 Is Essential for Maintenance of Cell Proliferation in the Mouse Embryonic Epiblast , 2003, Molecular and Cellular Biology.

[66]  J. Lupski,et al.  Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) Contiguous Gene Syndromes by Chromosome Engineering in Mice: Phenotypic Consequences of Gene Dosage Imbalance , 2003, Molecular and Cellular Biology.

[67]  G. Ojemann,et al.  Factors Predicting Outcome of Surgery for Intractable Epilepsy with Pathologically Verified Mesial Temporal Sclerosis , 2003, Epilepsia.

[68]  G. Ojemann,et al.  Atypical speech is rare in individuals with normal developmental histories , 2003, Neurology.

[69]  M M Haglund,et al.  Intraoperative hippocampal electrocorticography to predict the extent of hippocampal resection in temporal lobe epilepsy surgery. , 2000, Journal of neurosurgery.

[70]  I. Fried,et al.  Hippocampal N‐methyl‐D‐aspartate receptor subunit mRNA levels in temporal lobe epilepsy patients , 1999, Annals of neurology.

[71]  A. Bradley,et al.  Embryonic lethality and tumorigenesis caused by segmental aneuploidy on mouse chromosome 11. , 1998, Genetics.

[72]  I. Fried,et al.  Altered Hippocampal Kainate-Receptor mRNA Levels in Temporal Lobe Epilepsy Patients , 1998, Neurobiology of Disease.

[73]  D. Pinkel,et al.  Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation , 1998, The EMBO journal.

[74]  R. Palmiter,et al.  Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[75]  M. Berger,et al.  Paragangliomas of the sellar region: report of two cases. , 1993, Neurosurgery.